Post Profile

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

The common participation of oncogenic KRAS proteins in many of the most lethal human cancers, together with the ease of detecting somatic KRAS mutant alleles in patient samples, has spurred persistent and intensive efforts to develop drugs that inhibit KRAS activity. However, advances have been hindered by the pervasive inter- and intra-lineage diversity in the targetable mechanisms that underlie KRAS-driven cancers, limited pharmacological accessibility of many candidate synthetic-lethal interactions and the swift emergence of unanticipated resistance mechanisms to otherwise effective targeted therapies.
read more


Related Posts

Lung cancer signatures in blood samples may aid in early detection

Academics / General Science : ScienceDaily: Science Society

Lung cancer is one of the most common and deadly types of cancer. Mouse models of lung cancer recapitulate many features of the human disease and have provided new insight about cancer development, progression and treatment. Now, a ...

Women’s Wellness: Decreasing the most common gynecologic cancer

Health : Mayo Clinic News Blog

Endometrial cancer is the most common gynecologic cancer in the U.S., according to the American Cancer Society. An estimated 60,000 new cases of endometrial cancer – also known as uterine cancer – are diagnosed annually. Endometrial...

Could the KRAS Gene Help 'Personalize' Treatment for Pancreatic Cancer?

Health : Newswise Medical News

Researchers have known that treating a pancreatic cancer patient with human reovirus is only likely to be effective if the patient carries the mutant KRAS gene and not the wild-type KRAS gene. A recent Phase 2 clinical study by Onco...

Scientists Discover New Therapeutic Target for Lung Cancer Driven by KRAS

Health : Newswise Medical News

UT Southwestern Medical Center researchers have identified a new way to target lung cancer through the KRAS gene, one of the most commonly mutated genes in human cancer and one researchers have so far had difficulty targeting succes...

Novel oncogenic RET mutation found in small cell lung cancer

Academics / General Science : Science Codex

DENVER – For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation wit...


Copyright © 2016 Regator, LLC